Subscribe to the blog
- Healthcare is a central to our daily lives and policymakers in Washington, DC have an enormous influence and control over this vital aspect of society. Yet despite this, most people cannot see what goes on behind the scenes of health policy circles in our Nation’s capital. The mission of Neurosurgery Blog is to investigate and report on how healthcare policy affects patients, physicians and medical practice and to illustrate that the art and science of neurosurgery encompasses much more than brain surgery.
Category Archives: Drugs and Devices
The FDA and Regulation – Neurosurgery Partners with FDA for Patient Safety, Innovation and Regulatory Reform
Clemens M. Schirmer, MD, PhD, FAANS, FAHA (left) Vice-Chair, AANS/CNS Communications and Public Relations Committee Geisinger Wilkes Barre, PA Catherine Jeakle Hill (right) Senior Manager for Regulatory Affairs, Washington Office American Association of Neurological Surgeons (AANS) Congress of Neurological Surgeons … Continue reading
Cross Post – Efforts to Curb Opioid Misuse Must Preserve Patient Access to Medically-necessary Opioids
For today’s post, we wanted to highlight an opinion piece published by The Hill featuring neurosurgery’s own Robert F. Heary, MD, FAANS, professor of neurological surgery at the Rutgers New Jersey Medical School, and chair of the AANS/CNS Committee on … Continue reading
On February 14, 2017 the AANS and CNS released their 2017 legislative and regulatory agenda, which includes action items such as improving the health care delivery system, abolishing the Independent Payment Advisory Board (IPAB), expanding support for graduate medical education, … Continue reading